|
|
|
Volumn 136, Issue 7, 2003, Pages 45-52
|
|
The Canadian recommendations for the management of hypertension
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALDOSTERONE;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
AMILORIDE;
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
CAPTOPRIL;
CLONIDINE;
DIHYDROPYRIDINE DERIVATIVE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
DOXAZOSIN;
HYDRALAZINE;
ISOSORBIDE DINITRATE;
LOOP DIURETIC AGENT;
METHYLDOPA;
METIROSINE;
PHENOXYBENZAMINE;
PHENTOLAMINE;
PRAZOSIN;
SPIRONOLACTONE;
THIAZIDE DIURETIC AGENT;
ADRENAL CORTEX ADENOMA;
ALDOSTERONE BLOOD LEVEL;
AMBULATORY MONITORING;
BLOOD PRESSURE MEASUREMENT;
BLOOD PRESSURE MONITORING;
CANADA;
CARDIOVASCULAR RISK;
COMORBIDITY;
DIABETES MELLITUS;
DIET THERAPY;
DYSLIPIDEMIA;
ECHOCARDIOGRAPHY;
ELECTROCARDIOGRAM;
FOLLOW UP;
HUMAN;
HYPERALDOSTERONISM;
HYPERTENSION;
HYPERTENSIVE CRISIS;
HYPOKALEMIA;
LABORATORY TEST;
LIFESTYLE;
MEDICAL RECORD;
PATIENT EDUCATION;
PHEOCHROMOCYTOMA;
PLASMA RENIN ACTIVITY;
RENOVASCULAR HYPERTENSION;
REVIEW;
SYSTOLIC BLOOD PRESSURE;
TREATMENT CONTRAINDICATION;
|
|
EID: 0142245373
PISSN: 08286914
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|